| human | Q5 |
| P496 | ORCID iD | 0000-0001-7779-2796 |
| P735 | given name | William | Q12344159 |
| William | Q12344159 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q34744122 | A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q90147384 | Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q46084460 | Composite likelihood-based meta-analysis of breast cancer association studies. |
| Q38244501 | Exome sequence read depth methods for identifying copy number changes |
| Q53135921 | Exome-based linkage disequilibrium maps of individual genes: functional clustering and relationship to disease. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q91997144 | Genomic Landscape of Uterine Sarcomas Defined through Prospective Clinical Sequencing |
| Q90730304 | Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma |
| Q45733546 | Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women |
| Q98574423 | HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and its Association with Clinical Outcome |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q28943279 | Identification of inherited genetic variations influencing prognosis in early-onset breast cancer |
| Q112705960 | Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma |
| Q31150058 | Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q49252742 | Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer. |
| Q62644413 | Mutations in phospholipase C epsilon 1 are not sufficient to cause diffuse mesangial sclerosis |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36071595 | Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q90354482 | Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q35763565 | Whole genome sequences are required to fully resolve the linkage disequilibrium structure of human populations |
Search more.